Switch to:

Arrowhead Pharmaceuticals EV-to-Revenue

: 46.74 (As of Today)
View and export this data going back to 1997. Start your Free Trial

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Arrowhead Pharmaceuticals's enterprise value is $5,779.2 Mil. Arrowhead Pharmaceuticals's Revenue for the trailing twelve months (TTM) ended in Jun. 2020 was $123.7 Mil. Therefore, Arrowhead Pharmaceuticals's EV-to-Revenue for today is 46.74.

NAS:ARWR' s EV-to-Revenue Range Over the Past 10 Years
Min: -2.5   Med: 98.7   Max: 5303.9
Current: 46.75

-2.5
5303.9

During the past 13 years, the highest EV-to-Revenue of Arrowhead Pharmaceuticals was 5303.90. The lowest was -2.50. And the median was 98.70.

NAS:ARWR's EV-to-Revenue is ranked lower than
66% of the 867 Companies
in the Biotechnology industry.

( Industry Median: 18.77 vs. NAS:ARWR: 46.75 )

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2020-10-26), Arrowhead Pharmaceuticals's stock price is $59.10. Arrowhead Pharmaceuticals's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2020 was $1.23. Therefore, Arrowhead Pharmaceuticals's PS Ratio for today is 47.97.


Arrowhead Pharmaceuticals EV-to-Revenue Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Arrowhead Pharmaceuticals Annual Data
Sep10 Sep11 Sep12 Sep13 Sep14 Sep15 Sep16 Sep17 Sep18 Sep19
EV-to-Revenue Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 638.19 2,700.91 8.28 100.48 14.41

Arrowhead Pharmaceuticals Quarterly Data
Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20
EV-to-Revenue Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.71 14.41 36.22 18.95 33.56

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


Arrowhead Pharmaceuticals EV-to-Revenue Distribution

* The bar in red indicates where Arrowhead Pharmaceuticals's EV-to-Revenue falls into.



Arrowhead Pharmaceuticals EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Arrowhead Pharmaceuticals's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=5779.225/123.653
=46.74

Arrowhead Pharmaceuticals's current Enterprise Value is $5,779.2 Mil.
Arrowhead Pharmaceuticals's Revenue for the trailing twelve months (TTM) ended in Jun. 2020 was 43.293 (Sep. 2019 ) + 29.455 (Dec. 2019 ) + 23.529 (Mar. 2020 ) + 27.376 (Jun. 2020 ) = $123.7 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Arrowhead Pharmaceuticals  (NAS:ARWR) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Arrowhead Pharmaceuticals's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=59.10/1.232
=47.97

Arrowhead Pharmaceuticals's share price for today is $59.10.
Arrowhead Pharmaceuticals's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2020 was 0.429 (Sep. 2019 ) + 0.303 (Dec. 2019 ) + 0.231 (Mar. 2020 ) + 0.269 (Jun. 2020 ) = $1.23.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Arrowhead Pharmaceuticals EV-to-Revenue Related Terms


Arrowhead Pharmaceuticals EV-to-Revenue Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)